Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy
- PMID: 745211
- PMCID: PMC1013753
- DOI: 10.1136/jmg.15.6.409
Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy
Abstract
A total population study of chronic childhood spinal muscular atrophy (arrested Werdnig-Hoffmann disease, Kugelberg-Welander disease, SMA type II and III) was undertaken in north-east England to establish gene and carrier frequencies, incidence, and prevalence. The incidence of this disease was 1 in 24 100 live births. Prevalence was 1.20 per 100,000 of the general population. A technique for estimating an autosomal recessive gene frequency in the known presence of dominant new mutations (or phenocopies), using data from a segregation analysis, is described. Gene frequency was in the range (0.00451 to 0.00659 (95% confidence limits), with a working estimate of 0.0055. Carrier rates for the autosomal recessive gene concerned were 1 in 76 to 1 in 111 (95%) confidence limits), with a working estimate of 1 in 90 for genetic counselling purposes.
Similar articles
-
Segregation analysis of chronic childhood spinal muscular atrophy.J Med Genet. 1978 Dec;15(6):418-23. doi: 10.1136/jmg.15.6.418. J Med Genet. 1978. PMID: 745213 Free PMC article.
-
High incidence of spinal muscular atrophy type I (Werdnig - Hoffmann disease) in the Karaite community in Israel.Clin Genet. 1977 Oct;12(4):250-1. doi: 10.1111/j.1399-0004.1977.tb00934.x. Clin Genet. 1977. PMID: 912942
-
The gene frequency of acute Werdnig-Hoffmann disease (SMA type 1). A total population survey in North-East England.J Med Genet. 1973 Sep;10(3):260-5. doi: 10.1136/jmg.10.3.260. J Med Genet. 1973. PMID: 4774536 Free PMC article.
-
[Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].Schweiz Med Wochenschr. 1996 May 25;126(21):907-14. Schweiz Med Wochenschr. 1996. PMID: 8693311 Review. German.
-
Spinal muscular atrophies.Pediatr Clin North Am. 2015 Jun;62(3):743-66. doi: 10.1016/j.pcl.2015.03.010. Epub 2015 Apr 11. Pediatr Clin North Am. 2015. PMID: 26022173 Review.
Cited by
-
Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.Ther Adv Neurol Disord. 2013 May;6(3):147-60. doi: 10.1177/1756285612472386. Ther Adv Neurol Disord. 2013. PMID: 23634188 Free PMC article.
-
Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone health.J Child Neurol. 2014 Mar;29(3):374-80. doi: 10.1177/0883073812471857. Epub 2013 Jan 17. J Child Neurol. 2014. PMID: 23334077 Free PMC article.
-
RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns.Nucleic Acids Res. 2017 Jan 9;45(1):395-416. doi: 10.1093/nar/gkw731. Epub 2016 Aug 23. Nucleic Acids Res. 2017. PMID: 27557711 Free PMC article.
-
Mouse models of SMA: tools for disease characterization and therapeutic development.Hum Genet. 2012 Aug;131(8):1277-93. doi: 10.1007/s00439-012-1171-5. Epub 2012 Apr 29. Hum Genet. 2012. PMID: 22543872 Review.
-
Robust quantification of the SMN gene copy number by real-time TaqMan PCR.Neurogenetics. 2007 Nov;8(4):271-8. doi: 10.1007/s10048-007-0093-1. Epub 2007 Jul 24. Neurogenetics. 2007. PMID: 17647030
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical